Louise Tottie
Louise Tottie
Louise Tottie
Name
Position
Location

Louise Tottie

Partner - Patent Attorney
Partner - Patent Attorney
Stockholm, Sweden
Contact

With deep expertise in chemistry and years of experience as a patent attorney, Louise supports clients across sectors including organic, medicinal and polymer chemistry, medtech, and advanced materials. Drawing on her background in research and development, she brings specialist knowledge of how to capture, protect and leverage innovation to drive commercial returns and build market advantage.

Louise specialises in patent searching, drafting and prosecuting patent applications, oppositions, validity investigations and freedom-to-operate (FTO) analysis. As part of the firm's chemistry team, she works closely with other experts and attorneys to deliver strategic, commercially focused advice.

She joined the profession after several years in research and development. Her sector experience includes organic, medicinal, polymer and wood chemistry, as well as powder metallurgy, medtech, conductive films and bioanalytical sensors.

Louise is a member of the European Patent Institute (epi).

  • Preparing early-stage companies and researchers for fundraising and investor due diligence, including supporting two academics from Uppsala University in selling their patent-protected innovation just ten months after filing
  • Educating clients and other professionals on the essentials of IP, supporting the Swedish life sciences sector in its push to lead European innovation
  • Innovation capture and drafting patent applications for complex innovations, including adding late-stage innovations to existing portfolios to support long-term commercial success  
  • Prosecuting patents successfully in cases requiring responses to multiple objections and issues
  • Swedish and European Patent Attorney
  • PhD, Organic Chemistry, Royal Institute of Technology, Stockholm
  • MSc, Chemistry, Royal Institute of Technology, Stockholm
  • Member of the European Patent Institute (epi)
Tottie combines 15 years of in-house experience with a global pharmaceutical leader and nearly 20 years in private practice. She leverages her extensive career to meticulously draft applications, manage oppositions and conduct assessments.
IAM Patent 1000: The World’s Leading Patent Professionals, 2025
Louise’s extensive experience in medicinal chemistry, combined with her legal expertise and strategic approach, has been invaluable for our business. By ensuring our innovations are optimally protected, Louise has delivered real value for the company, and she is always a delight to work with.
Annica Rönnbäck, COO, QureTech Bio AB
  • IAM Patent 1000: Prosecution
  • MIP IP STARS: Patent Star

About Louise

Experience

Areas of expertise

Qualifications

Testimonials

Awards

Dark abstract geometric shapes creating a layered pattern with gradient shading.

How We Live Our Values: Ambition

Chemistry has always been my passion and is a central part of my life, both professionally and personally. I’m an active member of the Swedish Chemical Society and chaired its Organic Chemistry Committee for several years. I strive to give clients clear, practical advice on protecting their research and innovations, helping them turn ideas into commercial success.

In My Own Words

Having spent many years in research and development, I understand the time, effort, and dedication required to achieve an innovation. I measure my success by that of our team and our clients, and I find it especially rewarding when they achieve commercial and financial results from innovations we’ve helped protect.

Related News

IAM Patent 1000: The World's Leading Patent Professionals 2025

New Swedish Patent Act

IAM Patent 1000: The World's Leading Patent Professionals 2024

Potter Clarkson announces a host of firm-wide promotions

Description amendments: Will the EPO change its examination practice?

Description amendments: Will the EPO change its examination practice?

Seeing double: EPO does little to clarify prohibition on double patenting

Seeing double: EPO does little to clarify prohibition on double patenting

See All News